Soufflé Therapeutics Closes $135 Million Series B Round
Soufflé Therapeutics has raised $135 million in Series B funding, FinSMEs reports. No investors, valuation, or use of proceeds were disclosed in the report.
Topic
Souffle Therapeutics
Topic
Topic
Topic
Soufflé Therapeutics has raised $135 million in Series B funding, FinSMEs reports. No investors, valuation, or use of proceeds were disclosed in the report.